8-95041772-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_152416.4(NDUFAF6):c.477+146C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.473 in 711,900 control chromosomes in the GnomAD database, including 82,625 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.43 ( 14677 hom., cov: 31)
Exomes 𝑓: 0.48 ( 67948 hom. )
Consequence
NDUFAF6
NM_152416.4 intron
NM_152416.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0330
Publications
18 publications found
Genes affected
NDUFAF6 (HGNC:28625): (NADH:ubiquinone oxidoreductase complex assembly factor 6) This gene encodes a protein that localizes to mitochondria and contains a predicted phytoene synthase domain. The encoded protein plays an important role in the assembly of complex I (NADH-ubiquinone oxidoreductase) of the mitochondrial respiratory chain through regulation of subunit ND1 biogenesis. Mutations in this gene are associated with complex I enzymatic deficiency. [provided by RefSeq, Nov 2011]
NDUFAF6 Gene-Disease associations (from GenCC):
- Leigh syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- mitochondrial complex I deficiency, nuclear type 17Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
- primary Fanconi syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Leigh syndrome with leukodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Fanconi renotubular syndrome 5Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 8-95041772-C-T is Benign according to our data. Variant chr8-95041772-C-T is described in ClinVar as Benign. ClinVar VariationId is 1181913.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.67 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NDUFAF6 | NM_152416.4 | c.477+146C>T | intron_variant | Intron 4 of 8 | ENST00000396124.9 | NP_689629.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NDUFAF6 | ENST00000396124.9 | c.477+146C>T | intron_variant | Intron 4 of 8 | 2 | NM_152416.4 | ENSP00000379430.4 |
Frequencies
GnomAD3 genomes AF: 0.429 AC: 65152AN: 151796Hom.: 14676 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
65152
AN:
151796
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.485 AC: 271528AN: 559986Hom.: 67948 AF XY: 0.491 AC XY: 147738AN XY: 301152 show subpopulations
GnomAD4 exome
AF:
AC:
271528
AN:
559986
Hom.:
AF XY:
AC XY:
147738
AN XY:
301152
show subpopulations
African (AFR)
AF:
AC:
4567
AN:
15728
American (AMR)
AF:
AC:
17655
AN:
32790
Ashkenazi Jewish (ASJ)
AF:
AC:
9223
AN:
18500
East Asian (EAS)
AF:
AC:
21556
AN:
31386
South Asian (SAS)
AF:
AC:
34122
AN:
60366
European-Finnish (FIN)
AF:
AC:
18647
AN:
41180
Middle Eastern (MID)
AF:
AC:
1184
AN:
2384
European-Non Finnish (NFE)
AF:
AC:
150441
AN:
328108
Other (OTH)
AF:
AC:
14133
AN:
29544
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
6582
13164
19747
26329
32911
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1304
2608
3912
5216
6520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.429 AC: 65187AN: 151914Hom.: 14677 Cov.: 31 AF XY: 0.434 AC XY: 32196AN XY: 74240 show subpopulations
GnomAD4 genome
AF:
AC:
65187
AN:
151914
Hom.:
Cov.:
31
AF XY:
AC XY:
32196
AN XY:
74240
show subpopulations
African (AFR)
AF:
AC:
12219
AN:
41412
American (AMR)
AF:
AC:
7595
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
1732
AN:
3466
East Asian (EAS)
AF:
AC:
3565
AN:
5172
South Asian (SAS)
AF:
AC:
2698
AN:
4820
European-Finnish (FIN)
AF:
AC:
4738
AN:
10534
Middle Eastern (MID)
AF:
AC:
129
AN:
294
European-Non Finnish (NFE)
AF:
AC:
31071
AN:
67930
Other (OTH)
AF:
AC:
959
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1863
3727
5590
7454
9317
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
614
1228
1842
2456
3070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1961
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.